A key Medicare advisory panel reported on the program’s financial health, highlighting rising costs attributed to fraud, improper payments, and misaligned payment incentives. The Medicare Payment Advisory Commission’s 2026 report emphasized the need for policymakers to implement measures to ensure the program’s viability, noting that federal spending on Medicare has doubled from $500 billion in 2010 to $1 trillion in 2023.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://news.bloomberglaw.com/pharma-and-life-sciences/medicare-advisers-urge-payment-changes-to-rein-in-program-costs
